Drug
Tarlatamab
Data on this page refer exclusively to patients treated with
Tarlatamab combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
BiTE group page.
Drug Profile
| Therapeutic Class | Monoclonal Antibodies (mAbs) |
| Drug Class | bispecific T-cell engagers |
| Group | BiTE |
| Mechanism of Action | Bispecific T-cell engager |
